Mir-452-5p在早期结直肠癌上皮-间质转化(EMT)中的过表达作用。
Role of Mir-452-5p Overexpression in Epithelial-Mesenchymal Transition (EMT) in Early-stage Colorectal Cancer.
发表日期:2023
作者:
Yukiko Koyama, Shintaro Fujihara, Taiga Chiyo, Takanori Matsui, Sae Hamaya, Koji Fujita, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Hisakazu Iwama, Tsutomu Masaki
来源:
Cellular & Molecular Immunology
摘要:
微小RNA miR-452-5p 在多种肿瘤形成的进展中起着关键作用,但对早期结直肠癌(CRC)中上皮-间质转化(EMT)进展及其潜在机制的理解有限。我们旨在探索早期CRC中miRNA表达的变化,并研究这些miRNA在CRC中的作用。通过实时定量聚合酶链反应确定早期CRC组织和细胞中miR-452-5p的表达水平。此外,通过体外功能实验研究了miR-452-5p对CRC的生物学效应。miR-452-5p的表达水平在早期CRC组织中增加。我们发现miR-452-5p促进了CRC细胞的增殖,但抑制了上皮-间质转化。此外,miR-452-5p通过激活胞外信号调节激酶途径促进细胞增殖,并通过抑制Slug(Snail2)表达和上调E-cadherin表达来抑制细胞侵袭。miR-452-5p的表达在早期CRC中上调,抑制了CRC中的上皮-间质转化。这些发现表明miR-452-5p有潜力成为CRC的可行治疗靶点。
Copyright © 2023,International Institute of Anticancer Research(Dr. George J. Delinasios),保留所有权利。
The microRNA miR-452-5p holds a critical role in the progression of multiple tumor formations, but there is limited understanding regarding the epithelial-mesenchymal transition (EMT) progression and its underlying mechanisms in the early-stage colorectal cancer (CRC). We aimed to explore the change in miRNA expression in early-stage CRC and examine the role of these miRNAs in CRC.The expression levels of miR-452-5p in tissues and cells of early-stage CRC were determined by real-time quantitative polymerase chain reaction. Additionally, the biological effects of miR-452-5p on CRC were investigated by in vitro functional experiments.The expression levels of miR-452-5p were found increased in early-stage CRC tissue. We found that miR-452-5p promoted CRC cell proliferation but inhibited epithelial-mesenchymal transition. Furthermore, miR-452-5p promoted cell proliferation through activation of the extracellular signal-regulated kinase pathway, and inhibited cell invasion through suppression of Slug (Snail2) expression and up-regulation of E-cadherin expression.The expression of miR-452-5p is up-regulated in early CRC and suppresses epithelial-mesenchymal transition in CRC. These discoveries suggest that miR-452-5p has the potential to serve as a viable therapeutic target for CRC.Copyright © 2023, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.